Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

LSPedia partners with Pharma Logistics on supply chain efficiency

By Sean Whooley | August 20, 2024

This is the logo of Pharma Logistics.LSPedia and Pharma Logistics announced a strategic partnership to transform the pharmaceutical supply chain.

LSPedia, a SaaS solution leader, offers global product traceability. Pharma Logistics provides pharmaceutical reverse distribution. Pharma Logistics’ offerings ensure efficient and safe handling of pharmaceutical products throughout their end-of-life cycle. LSPedia brings to the partnership the OneScan solution for achieving complete compliance with FDA regulations. It delivers a transparent view of the pharmaceutical supply chain with real-time product tracing data. It seamlessly integrates with hospital and pharmacy systems to reduce redundant product scanning, streamline recall management and mitigate the risk of drug shortages.

The companies want to offer turnkey compliance, unprecedented data visibility and robust supply chain efficiency.

In the partnership, LSPedia and Pharma Logistics expect to provide a 360-degree view of the pharmaceutical supply chain. They hope to give pharmaceutical companies a single, trusted source of information to make informed business decisions faster and with greater confidence.

“We are delighted to offer LSpedia’s OneScan solution to our pharmacy customers. Our customers have consistently highlighted the challenge of managing complex DSCSA compliance requirements and ensuring accurate product traceability. By integrating OneScan, we are addressing these critical pain points and making advanced compliance technology more accessible,” said David A. Hargraves, CEO of Pharma Logistics. “This partnership enables us to provide a more seamless, efficient, and reliable solution, empowering our customers to stay ahead in the ever-evolving regulatory landscape.”

About The Author

Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Genentech roche
Roche, Genentech to build $700M drug manufacturing plant in North Carolina
These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE